What DCC Health & Beauty Solutions does

DCC Health & Beauty Solutions (operating commercially as HBI Health & Beauty Innovations / HBI Group) is a UK-headquartered contract development and manufacturing organization (CDMO) serving health, beauty, wellness, pharmaceutical, OTC medicine, and pet health brands. Founded in 1994 and headquartered in Runcorn, the group operates eight state-of-the-art manufacturing facilities spanning 1.2 million square feet across the United States and Europe, supported by 1,800+ skilled employees and a 70+ person R&D team that develops 500+ new formulations annually. Its core technology is multi-format contract manufacturing across twelve product capabilities including body care, capsules, chewables, effervescent tablets, facial skin care, gummies, hair care, medical devices, nutritional liquids, powders, soft gels, and tablets, supported by 72+ quality accreditations and a four-stage Discover-Develop-Validate-Launch innovation process.

The business model is B2B contract manufacturing on a quote-based, project-by-project pricing structure tied to product specifications, order volume, formulation complexity, and service scope (formulation development, manufacturing, packaging, and regulatory support). Revenue is generated through custom development and manufacturing services delivered through seven wholly-owned subsidiaries (HBI Amerilab Technologies, HBI Bittner, HBI Design Plus, HBI EuroCaps, HBI Ion Labs, HBI Laleham, and HBI Thompson & Capper), each focused on specific product formats or geographic markets. The go-to-market is sales-led direct engagement with brand managers and product development teams, supported by website content marketing, LinkedIn presence, and direct consultation CTAs.

Ownership transitioned in October 2024 when HBI Group became part of Ourvita Group, described as one of Europe's largest and most diversified CDMOs in the health and wellness sector. Earlier inorganic moves include the 2018 acquisition of Elite One Source Nutritional Services and the 2019 acquisition of Ion Labs, both expanding US dietary supplement capacity. The group reports 6 billion units produced annually, 452 combined years of expertise, and operations serving 120+ country destinations. AI deployment is currently limited to operational safety applications (AI-powered camera systems on forklift trucks).

Name

DCC Health & Beauty Solutions

Legal name

HBI Health & Beauty Innovations

Website

https://dcchealthandbeauty.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

501–1,000 employees

Short description

DCC Health & Beauty Solutions (HBI Group) is a UK-headquartered CDMO operating eight manufacturing facilities across the US and Europe, providing multi-format contract manufacturing of supplements, cosmetics, OTC medicines, and medical devices for global health, beauty, and wellness brands.

Ownership category

akta.pro rank

Product category

Contract Manufacturing Services

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Medical Equipment and Supplies Manufacturing (33911), Soap and Cleaning Compound Manufacturing (32561)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Contract manufacturing services
• Health and beauty manufacturing
• Nutritional supplements manufacturing
• Cosmetic contract manufacturing
• Pharmaceutical contract manufacturing

Headquarters

HQ city

Runcorn

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Contract Manufacturing Services: Full-service contract development and manufacturing (CDMO) for health, beauty, and wellness brands. Revenue generated through custom formulation development, manufacturing, and packaging of nutritional supplements, cosmetics, OTC medicines, and medical devices. Pricing based on product specifications, order volume, and service scope.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

DCC Health & Beauty Solutions operates as a contract development and manufacturing organization (CDMO) producing finished health, beauty, and personal care products for brand owners. The company manufactures nutritional supplements, OTC medicines, cosmetics, body care, hair care, facial skin care, and medical devices across multiple dosage formats including tablets, capsules, soft gels, gummies, chewables, effervescent tablets, powders, and nutritional liquids. Operations are delivered through a network of eight manufacturing facilities across the United States and Europe, producing approximately six billion units per year for clients in more than 120 countries.

Product overview

HBI Health & Beauty Innovations is a global contract manufacturing group operating as a multi-subsidiary platform with seven businesses: HBI Amerilab Technologies (effervescent and non-effervescent powders/tablets), HBI Bittner (medicines, medical devices, food supplements), HBI Design Plus (sachets, bottles, tubes packaging), HBI EuroCaps (softgels, nutritional gummies), HBI Ion Labs (dietary supplements), HBI Laleham (cosmetics, nutritional liquids, medical devices, medicines), and HBI Thompson & Capper (pharmaceutical supplements). The group offers comprehensive manufacturing capabilities across 12 product categories including body care, capsules, chewables, effervescent tablets, facial skin care, gummies, hair care, medical devices, nutritional liquids, powders, soft gels, and tablets. The platform approach unifies eight state-of-the-art manufacturing facilities serving health, beauty, OTC medicines, pet health, and pharmaceutical sectors across 120+ countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Tablets Manufacturing Contract manufacturing of tablet-form nutritional supplements and OTC health products for brand owners.
• Capsules Manufacturing Contract manufacturing of capsule-form supplements and OTC products for brand customers across health and wellness markets.
• Soft Gels Manufacturing Contract manufacturing of softgel encapsulated supplements and health products for brand owners.
• Gummies Manufacturing Contract manufacturing of gummy-form nutritional supplements and OTC products.
• Chewables Manufacturing Contract manufacturing of chewable-format supplements and OTC health products.
• Effervescent Tablets Manufacturing Contract manufacturing of effervescent tablet-form supplements and health products, leveraging a specialized effervescent technology capability.
• Powders Manufacturing Contract manufacturing of powdered supplements and nutritional products for brand customers.
• Nutritional Liquids Manufacturing Contract manufacturing of liquid nutritional supplements and beverages for brand owners.
• Body Care Manufacturing Contract manufacturing of body care personal care products for beauty and personal care brands.
• Facial Skin Care Manufacturing Contract manufacturing of facial skin care cosmetic products for beauty brands.
• Hair Care Manufacturing Contract manufacturing of hair care personal care products for beauty and personal care brands.
• Medical Devices Manufacturing Contract manufacturing of regulated medical device products for health and pharmaceutical brand owners.

Quantifiable outcome

• 500+ new formulas developed annually
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Ourvita GroupflagshipStrategic or Co-development Partner · 16 October 2024HBI Group announced it is now part of Ourvita Group, one of Europe's largest and most diversified CDMOs in the health & wellness sector. This partnership creates a powerful platform combining HBI's expertise with Ourvita's scale, bringing together extensive expertise, innovation, and opportunities to support growth in the health and beauty manufacturing sector.

Scale indicators9 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• Catalent: Global CDMO serving pharmaceutical, consumer health, and beauty customers across softgels, tablets, gummies, and other dosage forms. Highly comparable to HBI's integrated, multi-format health and beauty CDMO model, though at significantly larger scale.
• Aenova Group: European-headquartered CDMO with strong capabilities in solid dosage forms, softgels, liquids, and packaging for pharma and consumer health. Closely comparable to HBI on multi-format contract manufacturing for European brand customers.
• Recipharm: European CDMO offering formulation, manufacturing, and packaging of pharmaceuticals and consumer health products. Comparable to HBI's pharmaceutical and OTC medicine manufacturing footprint across multiple European sites.
• Fareva: French private CDMO serving pharmaceuticals, cosmetics, and home/personal care with multi-format manufacturing across Europe. Direct peer in the health and beauty contract manufacturing space, especially in beauty and OTC formats.
• Delpharm: European CDMO specialised in pharmaceutical and OTC manufacturing across multiple dosage forms. Comparable to HBI on regulated contract manufacturing for European brand customers, with similar multi-site, multi-format positioning.
• Roelmi HPC (formerly Colep): European CDMO serving personal care, cosmetics, and nutraceutical customers with contract manufacturing and packaging. Highly comparable to HBI's beauty and health manufacturing platform, particularly in body care, skin care, and liquid formats.
• LTS Lohmann Therapie-Systeme: Specialised CDMO focused on transdermal systems, oral thin films, and topical pharmaceutical products. Comparable to HBI's topical medical device and OTC manufacturing capabilities, especially at HBI Bittner and HBI Laleham.
• Adare Pharma Solutions: Global CDMO providing formulation, manufacturing, and packaging of oral dosage forms including tablets, capsules, and gummies. Comparable to HBI on health, nutrition, and OTC contract manufacturing, with similar format breadth.

Broad incumbents

• Lonza Group: Global CDMO leader with broad capabilities in small molecules, biologics, and consumer health. Comparable on CDMO business model and regulatory expertise, though much larger and more weighted to pharma/biotech than HBI's health & beauty focus.

Emerging players

• Bora Pharmaceuticals: Asia-based CDMO with growing presence in oral solid dose and consumer health manufacturing. Relevant emerging peer given its push into Western markets and overlap with HBI's health, nutrition, and OTC formats.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/1159093

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DCC Health & Beauty Solutions